Table 1
Cost effectiveness of tumour necrosis factor inhibitors
12
Agent
Reference
Cost per QALY (US$)
QALY, quality adjusted life year.
Infliximab
Wong
et al
47
30 500
Infliximab
Kobelt
et al
48
34 320
Etanercept
Brennan
et al
50
29 394
Adalimumab
Bansback
et al
53
28 924